查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球上游生物加工市場 2023-2030
市場調查報告書
商品編碼
1380389

全球上游生物加工市場 2023-2030

Global Upstream Bioprocessing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

全球上游生物加工市場預計在預測期內（2023-2030年）CAGR為11.1%。自動化上游生物加工優勢的增加，例如改進的製程控制、提高的產品品質、減少的變異性、增加的產量和效率以及節省的成本，推動了市場的成長。擴大採用自動化上游生物加工和改進的軟體是支持全球市場成長的關鍵因素。直接在生物生產實驗室捕獲資料可以幫助生物製程工程師提高製程理解，從而實現更穩健的製造流程並加快開發時間。各種上游生物反應器，用於自動化常規產品品質和細胞培養基分析。因此，市場參與者也專注於推出自動化上游生物加工解決方案，以進一步促進市場成長。例如，2023 年 9 月，沃特世公司推出了新的生物製程直接解決方案，旨在進一步簡化生物樣品的製備和分析。透過消除將生物反應器樣本送到中央實驗室進行分析的需要，新的解決方案使加速上游生物過程變得更加容易。 Waters OneLab (TM) 實驗室自動化軟體和新的預開發分析工作流程使生物製程工程師能夠捕捉高品質的生物程序

細分市場前景

全球上游生物加工市場按產品、工作流程和使用類型進行細分。根據產品，市場細分為生物反應器、細胞培養產品、過濾器、袋子和容器及其他（生物反應器配件）。根據工作流程，市場細分為培養基製備、細胞培養和細胞分離。此外，根據使用類型，市場分為多用途和單用途。在工作流程中，由於特定培養基配製的細胞培養物的開發不斷增加，對哺乳動物細胞生長和實驗結果產生顯著影響，預計培養基製備細分市場將佔據相當大的市場佔有率。培養基為細胞生長和調節細胞過程的化合物提供能量來源。

細胞培養產品細分市場預計將在全球上游生物加工市場中佔據相當大的佔有率

其中，細胞培養產品細分市場預計將在全球上游生物加工市場中佔據相當大的佔有率。分段生長歸因於實驗室中細胞系發育的影響越來越大，這些細胞系需要一種培養基來提供細胞培養物生存和增殖所需的營養。生長培養基還提供正確的滲透壓和 pH 值。 CAR T 細胞的製造傳統上依賴使用動物或人類血清，這些血清變化很大，並且可能含有外源性因子。血清需要嚴格的安全測試、篩選和儲存品質合適的批次，導致生產過程更加昂貴和耗時。例如，2023 年 5 月，Lonza Group Ltd. 推出了 TheraPEAK (R) T-VIVO (R) 細胞培養基，這是一種為最佳化 CAR T 細胞製造而開發的新型化學成分確定的培養基。此培養基不含動物源成分，可提高一致性和製程控制，並簡化法規核准，加快上市時間。

區域展望

全球上游生物加工市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，亞太地區預計將在全球市場中佔據顯著佔有率，因為技術日新月異，各公司不斷努力改進產品，重點關注研發。主要市場參與者包括BioSpectrum, Inc.、Fujifilm Holdings Corp.、Hash Biotech Labs、Samsung Biologics 等。

北美地區全球上游生物加工市場預計將以顯著的CAGR成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於主要生物製藥公司的存在、新生物分子和單株抗體研發投資的增加、慢性病負擔的增加以及發達的基礎設施的存在是推動該地區市場成長的主要因素。此外，自動化生物反應器的開發推動了該地區的成長，以安全、經濟高效且符合法規的方式生產臨床應用細胞產品。

由於生物相似藥/生物分子、單株抗體和微小治療胜肽生產研究的增加，該地區上游生物加工市場加速發展。對製程改進和清潔、安全、有效的生物分子生產燃料的需求導致了市場的擴張。採用專利細胞系的公司可以在細胞培養過程中獲得較高的成功率，並實現最小的監管風險和高效的商業生產。主要市場參與者包括 Corning Inc.、Patheon NV、PBS Biotech, Inc.、Thermo Fisher Scientific, Inc. 等。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Corning, Inc.
    • 概述
    • 財務分析
    • SWOT分析
  • Sartorius AG
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品分類的全球上游生物加工市場
    • 生物反應器
    • 細胞培養產品
    • 過濾器
    • 袋子和容器
    • 其他（生物反應器配件）
  • 按工作流程分類的全球上游生物加工市場
    • 媒體準備
    • 細胞培養
    • 細胞分離
  • 按用途類型分類的全球上游生物加工市場
    • 多用途
    • 一次使用

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • AGC Inc.
  • Applikon Biotechnology
  • Bio-Connect Inc.
  • BioProcess International
  • Boehringer Ingelheim GmbH
  • CellGenix GmbH
  • Cytiva LifeScience
  • Danaher Corp.
  • Eppendorf AG
  • Esco Pharma
  • Getinge AB
  • Infors HT
  • Lonza Group Ltd.
  • Merck KGaA
  • Pall Corp.
  • PBS Biotech, Inc.
  • VWR International, LLC
Product Code: OMR2027798

Title: Global Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors, Cell Culture Products, Filters, Bags and Containers and Others), by Workflow (Media Preparation, Cell Culture and Cell Separation), and by Use Type (Multi-Use and Single-Use),Forecast Period (2023-2030).

The global upstream bioprocessing market is anticipated to grow at a CAGR of 11.1% during the Forecast Period (2023-2030). An increase in advantage of automated upstream bioprocessing such as improved process control, enhanced product quality, reduced variability, increased throughput and efficiency, and cost savings drive the growth of market. The growing adoption of automated upstream bioprocessing with improved software is the key factor supporting the growth of the market globally. Capturing data directly at the bio production laboratory can help bioprocess engineers improve process understanding, leading to more robust manufacturing processes and accelerated development timelines. Various upstream bioreactors to automate routine product quality and cell culture media analyses. Hence, the market players are also focusing on launching automated Upstream Bioprocessing solutions that further bolster the market growth. For instance, in September 2023, Waters Corp. launched new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating the need to send bioreactor samples to a central laboratory for analysis, the new solutions make it even easier to accelerate upstream bioprocess. Waters OneLab™ laboratory automation software and new pre-developed analytical workflow allow bioprocess engineers to capture high-quality bioprocess

Segmental Outlook

The global upstream bioprocessing market is segmented on the product, workflow, and use type. Based on the product, the market is sub-segmented into bioreactors, cell culture products, filters, bags and containers and others (bioreactors accessories). Based on the workflow, the market is sub-segmented into media preparation, cell culture and cell separation. Further, on the basis of use type, the market is sub-segmented into multi-use and single-use. Among the workflow, the media preparation sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of specific media-formulated cell cultures that significantly impact mammalian cell growth and experimental outcomes. Culture media provide a source of energy for cell growth and compounds that regulate cellular processes.

The Cell Culture Products Sub-Segment is Anticipated to Hold a Considerable Share of the Global Upstream Bioprocessing Market

Among the products, the cell culture products sub-segment is expected to hold a considerable share of the global upstream bioprocessing market. The segmental growth is attributed to the growing influence of the development of cell lines in the lab that require a medium that supplies the nutrients necessary for cell cultures to survive and proliferate. The growth media also provides the correct osmolality and pH. The manufacture of CAR T-cells has traditionally relied on the use of animal or human serum, that is highly variable and may contain adventitious agents. Serum requires stringent safety testing, screening, and stockpiling of suitable-quality batches, making for a more costly and time-consuming manufacturing process. For instance, in May 2023, Lonza Group Ltd. launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture. Free from animal-origin components, the medium improves consistency and process control and simplifies regulatory approval for faster time-to-market.

Regional Outlook

The global Upstream Bioprocessing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rapid technological advancements and companies are constantly working towards the improvement of their products with a major focus on research and development. The key market players include BioSpectrum, Inc., Fujifilm Holdings Corp., Hash Biotech Labs, Samsung Biologics and others.

The North America Region is Expected to Grow at a Significant CAGR in the Global Upstream Bioprocessing Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the presence of major biopharmaceutical companies, increasing investment for research and development of new biomolecules & mAbs, increasing chronic disease burden, and the presence of developed infrastructure are major factors that drive the market growth in this region. Moreover, the development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications has driven the region's growth.

The market for upstream bioprocessing in the region is accelerated by an increase in research into the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides. The demand for process improvement and clean, secure, and effective biomolecule production fuels results in the market's expansion. Companies adopting patented cell lines result in a high success rate in the cell cultivation process and enable minimal regulatory risk and efficient commercial production. The key market player includes Corning Inc., Patheon N.V., PBS Biotech, Inc., Thermo Fisher Scientific, Inc. and others.

Market Players Outlook

The major companies serving the upstream bioprocessing market include: Corning, Inc., Eppendorf AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2023, Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up capabilities. Together, Cytiva and Culture Biosciences aims to bring to customers new bioprocess solutions that use digitization, in-silico approaches, and virtual monitoring and control of experiments.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global upstream bioprocessing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Corning, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
  • 3.3. Sartorius AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Upstream Bioprocessing Market by Product
    • 4.1.1. Bioreactors
    • 4.1.2. Cell Culture Products
    • 4.1.3. Filters
    • 4.1.4. Bags and Containers
    • 4.1.5. Others (Bioreactors Accessories)
  • 4.2. Global Upstream Bioprocessing Market by Workflow
    • 4.2.1. Media Preparation
    • 4.2.2. Cell Culture
    • 4.2.3. Cell Separation
  • 4.3. Global Upstream Bioprocessing Market by Use Type
    • 4.3.1. Multi-Use
    • 4.3.2. Single-Use

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AGC Inc.
  • 6.2. Applikon Biotechnology
  • 6.3. Bio-Connect Inc.
  • 6.4. BioProcess International
  • 6.5. Boehringer Ingelheim GmbH
  • 6.6. CellGenix GmbH
  • 6.7. Cytiva LifeScience
  • 6.8. Danaher Corp.
  • 6.9. Eppendorf AG
  • 6.10. Esco Pharma
  • 6.11. Getinge AB
  • 6.12. Infors HT
  • 6.13. Lonza Group Ltd.
  • 6.14. Merck KGaA
  • 6.15. Pall Corp.
  • 6.16. PBS Biotech, Inc.
  • 6.17. VWR International, LLC

LIST OF TABLES

  • 1. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL UPSTREAM BIOPROCESSING BIOREACTORS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL UPSTREAM BIOPROCESSING CELL CULTURE PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL UPSTREAM BIOPROCESSING FILTERS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL UPSTREAM BIOPROCESSING BAGS AND CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 6. GLOBAL UPSTREAM BIOPROCESSING OTHERS PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 7. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 8. GLOBAL UPSTREAM MEDIA PREPARATION BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL UPSTREAM CELL CULTURE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 10. GLOBAL UPSTREAM CELL SEPARATION BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 11. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 12. GLOBAL UPSTREAM BIOPROCESSING FOR MULTI-USE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 13. GLOBAL UPSTREAM BIOPROCESSING FOR SINGLE-USE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 14. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 22. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORK FLOW, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL UPSTREAM BIOPROCESSING BIOREACTORS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL UPSTREAM BIOPROCESSING CELL CULTURE PRODUCTS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL UPSTREAM BIOPROCESSING FILTERS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL UPSTREAM BIOPROCESSING BAGS AND CONTAINERS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL UPSTREAM BIOPROCESSING OTHERS PRODUCT MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY WORKFLOW, 2022 VS 2030 (%)
  • 8. GLOBAL UPSTREAM MEDIA PREPARATION BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL UPSTREAM CELL CULTURE BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL UPSTREAM CELL SEPARATION BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY USE TYPE, 2022 VS 2030 (%)
  • 12. GLOBAL UPSTREAM BIOPROCESSING FOR MULTI-USE MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL UPSTREAM BIOPROCESSING FOR SINGLE-USE MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 15. US UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)